Pharmacotherapy & CM for Opioid and Cocaine Dependence

Conditions

Improve Memory | Impulse Control | Lower Cocaine Use | Treatment for Cocaine Addiction

What is the purpose of this trial?

The purpose of this study is to compare the efficacy of the combined treatment modafinil + Contingency Management (CM) to either treatment condition alone or to yoked-controls on cocaine abstinence.

To investigate the role of modafinil-related improvements in memory, impulse control, and attention in mediating cocaine abstinence.



Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute on Drug Abuse (NIDA)
Yale University
Dates:
May 2008
Last Updated:
December 11, 2013
Study HIC#:
0705002636

Clinicaltrials.gov ID: NCT00838981